Telomere Fusion to Chromosome Breaks Reduces Oncogenic Translocations and Tumour Formation

Qi, Ling,Strong, Margaret A.,Karim, Baktiar O.,Huso, David L.,Greider, Carol W.
DOI: https://doi.org/10.1038/ncb1276
IF: 21.3
2005-01-01
Nature Cell Biology
Abstract:Telomeres protect chromosome ends from fusion, degradation and recombination. Loss of telomere function has opposite effects on tumorigenesis: apoptosis, which inhibits tumour growth, and genomic instability, which accelerates tumour formation. Here we describe a new mechanism by which short telomeres inhibit tumorigenesis through interference with oncogenic translocations. In mice that are null for both ataxia-telangiectasia-mutated (Atm) and telomerase RNA (mTR), the first generation (G1) Atm−/− mTR−/− mice have a lower rate of tumour formation than Atm−/− mTR+/+ mice. These Atm−/− mTR−/− G1 tumours show no increase in either apoptosis or overall genomic instability. Strikingly, the tumours show a high fraction of translocations containing telomere signals at the translocation junctions. Translocations of the T-cell receptors on chromosome 14, which initiate tumorigenesis, were interrupted by fusion with telomeres. Telomere repeats were also detected at the translocation junctions in pre-malignant thymocytes. We propose that telomere fusion to DNA double-strand breaks competes with the generation of oncogenic translocations and thus reduces tumour formation.
What problem does this paper attempt to address?